跳至主要内容
临床试验/NCT07084480
NCT07084480招募中不适用

Riesenzellarteriitis - Wege Zur "Precision Medicine"

Wuerzburg University Hospital1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2025年11月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
400
试验地点
1
主要终点
Incidence of aortic adverse events

研究概览

简要总结

Long-term follow-up of aortal adverse events, as well as glucocortioid-associated adverse events in patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).

详细描述

In this non-interventional cohort study the following aspects should be addressed:

  • Can regular imaging procedures help to better assess the risk of aortic aneurysms and dissections over a period of 5-10 years after initial diagnosis of GCA?
  • Which prognostic factors correlate with aortic events?
  • What conclusions can be drawn about glucocorticoid-associated side effects over the longer (5-year) course?
  • Can modern imaging in correlation with standardized clinical examination, serological markers and immunophenotypic testing define patient clusters within the clinically heterogeneous disease spectrum of GCA and PMR with the aim of individualizing therapy?
  • What is the value of orbital MRI together with an ophthalmologic examination including fudoscopy and optical coherence tomography (OCT) in the detection of ischemic manifestations of GCA?
  • Can a contrast agent-saving MRI technique (with 25 % less contrast agent) be used in GCA without impairing signal quality?
  • Can rare lymphocyte populations be found by immunophenotyping, which provide information on the probability of recurrence or allow therapy control?

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age greater or similar to 18 years
  • Primary diagnosis of GCA or PMR

排除标准

  • Age under 18 years
  • lack of capacity to consent

结局指标

主要结局

Incidence of aortic adverse events

时间窗: Within 5 years

Aortic adverse events include new foramation or progress of aortic aneurysms, and aortic dissection

次要结局

  • Incidence of glucocorticoid-related adverse events(within 5 years)
  • Detection of ischemic complications in the eyes(within 5 years)
  • Performance of gadopiclenol in detecting vessel wall inflammation(within 5 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验